Print

Purpose

The purpose of this study is to characterize pulmonary hemodynamic profiles, with a focus on PVR subtypes, in patients with left-sided valvular heart disease undergoing aortic or mitral valve intervention, and to identify patterns predicting reversibility of TR and RV dysfunction.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ≥18 years old; AND - Scheduled for valve procedures

Exclusion Criteria

  • Congenital heart disease (except for bicuspid aortic valve), OR - Carcinoid heart disease, OR - Valvular mass, OR - Endocarditis, OR - Any other condition that, in the opinion of the investigator, would impair their ability to complete the study

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Aortic Intervention
  • Diagnostic Test: Echocardiogram
    An echocardiogram will be performed during the patient's routinely scheduled right heart catheterization.
Mitral Intervention
  • Diagnostic Test: Echocardiogram
    An echocardiogram will be performed during the patient's routinely scheduled right heart catheterization.
Tricuspid intervention
  • Diagnostic Test: Echocardiogram
    An echocardiogram will be performed during the patient's routinely scheduled right heart catheterization.

Recruiting Locations

Mayo Clinic in Rochester
Rochester, Minnesota 55905
Contact:
Dr. Borlaug's Research Team
(507) 255-2200

More Details

Status
Recruiting
Sponsor
Mayo Clinic

Study Contact

Annabelle Fuenffinger
507-422-3801
fuenffinger.annabelle@mayo.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.